Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Early research (Phase 1)Active Not RecruitingNCT00102648What this trial is testingLonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with TemozolomideWho this might be right forMalignant Supratentorial NeoplasmRecurrent GlioblastomaRecurrent Gliosarcoma M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT00095940What this trial is testingLapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System TumorsWho this might be right forRecurrent Childhood Anaplastic AstrocytomaRecurrent Childhood Brain Stem GliomaRecurrent Childhood Ependymoma+5 more National Cancer Institute (NCI) 52
Early research (Phase 1)Study completedNCT01682746What this trial is testingPhotodynamic Therapy (PDT) for Recurrent Pediatric Brain TumorsWho this might be right forBrain Tumor, Recurrent Harry T Whelan, MD 5
Testing effectiveness (Phase 2)UnknownNCT03916757What this trial is testingV-Boost Immunotherapy in Glioblastoma Multiforme Brain CancerWho this might be right forGlioblastoma MultiformeGlioma of Brain Immunitor LLC 20
Early research (Phase 1)Study completedNCT00458731What this trial is testingBevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic AstrocytomaWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+59 more National Cancer Institute (NCI) 57
Early research (Phase 1)Study completedNCT00526812What this trial is testingA Safety Study of RTA 744 in Patients With Recurrent High-Grade GliomasWho this might be right forGlioma Biogen 54
Testing effectiveness (Phase 2)Study completedNCT04238819What this trial is testingAbemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including NeuroblastomaWho this might be right forRelapsed Solid TumorRefractory Solid Tumor Eli Lilly and Company 47
Early research (Phase 1)Study completedNCT00006246What this trial is testingBusulfan in Treating Children and Adolescents With Refractory CNS CancerWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorLeukemia+4 more Pediatric Brain Tumor Consortium 28
Early research (Phase 1)Study completedNCT02444546What this trial is testingWild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain TumorsWho this might be right forChildhood AstrocytomaChildhood Atypical Teratoid/Rhabdoid TumorDiffuse Intrinsic Pontine Glioma+7 more Mayo Clinic 6
Early research (Phase 1)Study completedNCT00003876What this trial is testingInternal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Barrett Cancer Center
Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Early research (Phase 1)Study completedNCT00303940What this trial is testingTalabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorKidney Cancer+5 more National Institutes of Health Clinical Center (CC) 26
Testing effectiveness (Phase 2)Ended earlyNCT00014443What this trial is testingTopotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Rush University Medical Center 5
Large-scale testing (Phase 3)Ended earlyNCT03149575What this trial is testingVAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBMWho this might be right forGlioblastoma MultiformeGlioblastomaGlioma+2 more DelMar Pharmaceuticals, Inc. 2
Testing effectiveness (Phase 2)Study completedNCT00301418What this trial is testingOral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic AstrocytomaWho this might be right forGlioblastoma MultiformeAnaplastic Astrocytoma Northwell Health 11
Not applicableStudy completedNCT00002485What this trial is testingDevelopment of Strategies to Increase Enrollment in Clinical Trials for Children With CancerWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more Children's Oncology Group 359
Testing effectiveness (Phase 2)Ended earlyNCT02743078What this trial is testingOptune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent GlioblastomaWho this might be right forGlioblastomaGliomaGliosarcoma RTOG Foundation, Inc. 3
Testing effectiveness (Phase 2)Study completedNCT00008008What this trial is testingThiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Herbert Irving Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00014573What this trial is testingChemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain CancerWho this might be right forBrain and Central Nervous System Tumors Barbara Ann Karmanos Cancer Institute